In addition to the increased risk of lymphatic metastasis, high NRP2 and low SEMA3F expression has been associated with an increase in tumor aggressiveness, evidenced as an increase in the capacity for proliferation and infiltration [12,13,14,18]. The gene discussed is SEMA3F; the disease is neoplasm.